Fully Magnetically Levitated Left Ventricular Assist System for Treating Advanced HF A Multicenter Study
ConclusionsThe results show that the fully magnetically levitated centrifugal-flow chronic LVAS is safe, with high 30-day and 6-month survival rates, a favorable adverse event profile, and improved quality of life and functional status. (HeartMate 3™ CE Mark Clinical Investigation Plan [HM3 CE Mark]; NCT02170363)
Source: Journal of the American College of Cardiology - Category: Cardiology Source Type: research
More News: Bleeding | Cardiology | Gastroenterology | Heart | Heart Failure | Heart Transplant | Stroke | Study | Thrombosis | Transplant Surgery | Transplants